Carl L.G. Hansen, Ph.D.

Carl L.G. Hansen, Ph.D.

Chief Executive OfficeratAbCellera Biologics· In proxies 2021–2025

Pay in FY2025-24% from the year before · AbCellera Biologics stock +16.7% the same year

Carl L.G. Hansen, Ph.D. was paid $6.3M in FY2025 (Dec), down 24%. AbCellera Biologics stock rose 16.7% that year.

Pay$100 in the stock at the end of FY20 → $8
Pay is from the Summary Compensation Table of each AbCellera Biologics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AbCellera BiologicsPublic company · 5 yr
    • Chief Executive Officer2021 – Present · 5 yrStock in role -68%
  2. Resolution DiagnosticsPublic company · 1 yr
    • Director2015 – 2016 · 1 yrNo stock prices for these years
  3. Precision NanoSystems Inc.Public company · 4 yr
    • Director2011 – 2015 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?